Definitions and guidelines for research on antibiotic persistence

Abstract

More than 70 years ago, Hobby 1 and Bigger 2 observed that antibiotics that are considered bactericidal and kill bacteria in fact fail to sterilize cultures. Bigger realized that the small number of bacteria that manage to survive intensive antibiotic treatments are a distinct subpopulation of bacteria that he named 'persisters'. Fuelled in part by increasing concerns about antibiotic resistance but also by technological advances in single-cell analyses, the past 15 years have witnessed a great deal of research on antibiotic persistence by investigators with different backgrounds and perspectives. As the number of scientists that tackle the puzzles and challenges of antibiotic persistence from many different angles has profoundly increased, it is now time to agree on the basic definition of persistence and its distinction from the other mechanisms by which bacteria survive exposure to bactericidal antibiotic treatments 3. Several approaches have independently emerged to define and measure persistence. Research groups following seemingly similar procedures may reach different results, and careful examination of the experimental procedures often reveals that results of different groups cannot be compared. During the European Molecular Biology Organization (EMBO) Workshop 'Bacterial Persistence and Antimicrobial Therapy' (10-14 June 2018) in Ascona, Switzerland, which brought together 121 investigators involved in antibiotic persistence research from 21 countries, a discussion panel laid the main themes for a Consensus Statement on the definition and detection procedure of antibiotic persistence detailed below. In light of the potential role that antibiotic persistence can have in antibiotic treatment regimens, it is our hope that clarification and standardization of experimental procedures will facilitate the translation of basic science research into practical guidelines. Defining the persistence phenomena We adopt here a phenomenological definition of antibiotic persistence that is based on a small set of observations that can be made from experiments performed in vitro and that does not assume a specific mechanism. We focus on the differences and similarities between antibiotic persistence and other processes enabling bacteria to survive exposure to antibiotic treatments that could kill them, such as resistance, tolerance and heteroresistance. We identify different types of persistence that should be measured differently to obtain meaningful results; therefore, the definition of these types goes beyond semantics. For the more mathematically oriented readers, we provide a mathematical definition of the

Proteolytic queues at ClpXP increase antibiotic tolerance

“…While most published articles focus on methods that reduce persister levels, conditions that increase their levels are integral to understanding the causative mechanisms of action and developing new drugs. As many persister studies incidentally examine antibiotic tolerance 5,6 , it follows that some of the above mechanisms may play a role in antibiotic tolerance.…”

Suppressing chemoresistance in lung cancer via dynamic phenotypic switching and intermittent therapy

“…Unlike in microbiology where the terms persistence, tolerance and resistance are well defined (Brauner et al, 2016), rigorous definitions of these terms are lacking in cancer (Salgia and Kulkarni, 2018). In bacteria, persisters are defined as transiently tolerant variants that allow populations to avoid eradication by antibiotics (Balaban et al, 2019). Persistence is linked to preexisting heterogeneity in the population and is modulated by phenotypic switching in normally growing cells.…”

Switching Logistic Maps to Design Cycling Approaches Against Antimicrobial Resistance

“…The most adequate framework to represent the drug effects on a disease is with the corresponding PK/PD dynamics (pharmacokinetics and pharmadynamics). To quantify bacterial resistance, the minimum inhibitory concentration (MIC) is used to measure the lowest concentration of an antibiotic to prevent bacterial replication [4]. Previous control engineering works [20] formulated the scheduling of drugs in an impulsive framework.…”

“…Antimicrobials such as antibiotics and antivirals are powerful weapons to fight against infections. However, the misuse and overuse of drugs have led to drug resistance, which can be roughly defined as the ability of a microorganism to replicate in the presence of a drug [4]. Truly, during the course of an infection, pathogens can evolve genetically to generate resistance to a given drug.…”